(Total Views: 674)
Posted On: 03/27/2020 7:55:03 AM
Post# of 149108
Good morning/evening.
These are very good news !!!
1) Some patients have been, and will be, saved by Leronlimab !!!. This should be enough to have all of us jumping up and down !!!. We where a small part of it. Congratulations CYDY investors
(longs)
2) The silence of Nader was simply being very busy making sure Leronlimab will reach whomever needed it rapidly and filing IND modifications. A lesson to those that think that he is only about PR'ing and talking the talk rather than walking the walk.
3) Dr. Patterson once more "hits it out of the park". Not only he suggested the MOA for COVID, but, obviously his company has followed up and documented the whole reaction to Leronlimab from the patients (at least the first ones). There is nothing better than scientific evidence of the efficacy of the drug and we have it.
4) Obviously FDA, presented with evidence, has lifted IND restrictions to be able to use Leronlimab swiftly to more patients in need. Soon there will be many more than 7, and more hospitals using it. A snow ball has started rolling.
5) FDA is probably now changing it's tune to CYDY. If we succeed in these difficult circumstances, and the drug shows therapeutic benefit (which more and more seems to be the case), we will have our well deserved place. This will affect also the other applications. Remember:
6) Last but no least, it would seem that, Dr. Patterson being right once more, the MOA of Leronlimab has been confirmed. This is HUGE in my perspective. Not that I had any doubts, this goes to the naysayers and lost souls still out there
So, a lot to be happy about ... Feel really good for those two patients and the next 5 and more that will probably be helped by CYDY.
These are very good news !!!
1) Some patients have been, and will be, saved by Leronlimab !!!. This should be enough to have all of us jumping up and down !!!. We where a small part of it. Congratulations CYDY investors
(longs) 2) The silence of Nader was simply being very busy making sure Leronlimab will reach whomever needed it rapidly and filing IND modifications. A lesson to those that think that he is only about PR'ing and talking the talk rather than walking the walk.
3) Dr. Patterson once more "hits it out of the park". Not only he suggested the MOA for COVID, but, obviously his company has followed up and documented the whole reaction to Leronlimab from the patients (at least the first ones). There is nothing better than scientific evidence of the efficacy of the drug and we have it.
4) Obviously FDA, presented with evidence, has lifted IND restrictions to be able to use Leronlimab swiftly to more patients in need. Soon there will be many more than 7, and more hospitals using it. A snow ball has started rolling.
5) FDA is probably now changing it's tune to CYDY. If we succeed in these difficult circumstances, and the drug shows therapeutic benefit (which more and more seems to be the case), we will have our well deserved place. This will affect also the other applications. Remember:
Quote:
A leading academic medical center has administered the test medication, Leronlimab, in two of their sickest COVID-19 patients.
6) Last but no least, it would seem that, Dr. Patterson being right once more, the MOA of Leronlimab has been confirmed. This is HUGE in my perspective. Not that I had any doubts, this goes to the naysayers and lost souls still out there
So, a lot to be happy about ... Feel really good for those two patients and the next 5 and more that will probably be helped by CYDY.
(12)
(0)Scroll down for more posts ▼
